JPWO2020142725A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020142725A5 JPWO2020142725A5 JP2021538996A JP2021538996A JPWO2020142725A5 JP WO2020142725 A5 JPWO2020142725 A5 JP WO2020142725A5 JP 2021538996 A JP2021538996 A JP 2021538996A JP 2021538996 A JP2021538996 A JP 2021538996A JP WO2020142725 A5 JPWO2020142725 A5 JP WO2020142725A5
- Authority
- JP
- Japan
- Prior art keywords
- mir
- item
- lnp
- virus
- copies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024143254A JP2024167285A (ja) | 2019-01-04 | 2024-08-23 | カプセル化ポリヌクレオチド及び使用方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962788504P | 2019-01-04 | 2019-01-04 | |
| US62/788,504 | 2019-01-04 | ||
| US201962895135P | 2019-09-03 | 2019-09-03 | |
| US62/895,135 | 2019-09-03 | ||
| PCT/US2020/012237 WO2020142725A1 (en) | 2019-01-04 | 2020-01-03 | Encapsulated rna polynucleotides and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024143254A Division JP2024167285A (ja) | 2019-01-04 | 2024-08-23 | カプセル化ポリヌクレオチド及び使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022516318A JP2022516318A (ja) | 2022-02-25 |
| JPWO2020142725A5 true JPWO2020142725A5 (https=) | 2023-01-19 |
| JP2022516318A5 JP2022516318A5 (https=) | 2023-01-19 |
Family
ID=71406664
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021538996A Pending JP2022516318A (ja) | 2019-01-04 | 2020-01-03 | カプセル化ポリヌクレオチド及び使用方法 |
| JP2024143254A Pending JP2024167285A (ja) | 2019-01-04 | 2024-08-23 | カプセル化ポリヌクレオチド及び使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024143254A Pending JP2024167285A (ja) | 2019-01-04 | 2024-08-23 | カプセル化ポリヌクレオチド及び使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220117902A1 (https=) |
| EP (1) | EP3906039A4 (https=) |
| JP (2) | JP2022516318A (https=) |
| KR (1) | KR20210113260A (https=) |
| CN (1) | CN113453699A (https=) |
| AU (1) | AU2020204989A1 (https=) |
| BR (1) | BR112021013155A2 (https=) |
| CA (1) | CA3124524A1 (https=) |
| IL (1) | IL284433A (https=) |
| MX (1) | MX2021008146A (https=) |
| SG (1) | SG11202107282VA (https=) |
| TW (1) | TW202043480A (https=) |
| WO (1) | WO2020142725A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113166783B (zh) | 2018-10-09 | 2024-10-11 | 不列颠哥伦比亚大学 | 包含无有机溶剂和去污剂的转染活性囊泡的组合物和系统以及与之相关的方法 |
| AU2020315800A1 (en) | 2019-07-19 | 2022-03-03 | Seneca Therapeutics, Inc. | Second generation seneca valley virus oncolytic therapy: compositions and methods thereof |
| CN114514323A (zh) * | 2019-08-05 | 2022-05-17 | 复诺健生物科技加拿大有限公司 | 遗传修饰的肠病毒载体 |
| EP4271389A4 (en) * | 2020-12-29 | 2026-04-08 | Rejuvenation Tech Inc | COMPOSITIONS AND METHODS FOR ADMINISTRATING RNA |
| AU2022206676A1 (en) * | 2021-01-06 | 2023-08-24 | Elevatebio Technologies, Inc. | Encapsulated rna polynucleotides and methods of use |
| WO2022159508A1 (en) * | 2021-01-19 | 2022-07-28 | Seneca Therapeutics, Inc. | Armed seneca valley virus oncolytic therapy compositions and methods thereof |
| EP4297728A1 (en) * | 2021-02-23 | 2024-01-03 | Poseida Therapeutics, Inc. | Compositions and methods for delivery of nucleic acids |
| IL307319A (en) * | 2021-03-31 | 2023-11-01 | Rejuvenation Tech Inc | Compositions and methods for delivery of rna |
| AU2022328856A1 (en) * | 2021-08-17 | 2024-01-18 | Monash University | Lipid nanoparticle formulations |
| CA3234320A1 (en) * | 2021-09-30 | 2023-04-06 | Nof Corporation | Lipid nanoparticle used for delivering nucleic acid to brain tissue |
| WO2023054242A1 (ja) * | 2021-09-30 | 2023-04-06 | 日油株式会社 | 核酸をリンパ管内皮細胞に送達するために用いられる脂質ナノ粒子 |
| CN113980915B (zh) * | 2021-11-04 | 2023-07-07 | 江苏省人民医院（南京医科大学第一附属医院） | 一种新型的表达cxcl10的复制型溶瘤腺病毒和应用 |
| FR3129833B1 (fr) | 2021-12-03 | 2024-09-06 | Univ Claude Bernard Lyon | Nanoparticules pour la liberation d’acides nucleiques |
| WO2023165583A1 (zh) * | 2022-03-04 | 2023-09-07 | 益杰立科(上海)生物科技有限公司 | 靶向眼部细胞的递送系统和方法 |
| WO2024009316A1 (en) * | 2022-07-04 | 2024-01-11 | Bharat Biotech International Limited | Cationic lipid based composition, formulation and use for nucleic acid vaccine delivery and preparation thereof |
| CN115227674B (zh) * | 2022-08-05 | 2023-07-04 | 武汉滨会生物科技股份有限公司 | 包封的溶瘤病毒遗传物质及其应用 |
| WO2024086810A1 (en) * | 2022-10-21 | 2024-04-25 | Georgia Tech Research Corporation | Lymphatic endothelial cell-specific lipid nanoparticle and uses thereof |
| EP4704855A1 (en) * | 2023-04-26 | 2026-03-11 | Saliogen Therapeutics, Inc. | Lipid nanoparticle (lnp) formulations |
| KR20250042873A (ko) | 2023-09-20 | 2025-03-28 | 한국과학기술연구원 | 종양 표적 리간드를 포함하는 지질나노입자, 이의 제조방법 및 이를 포함하는 약학 조성물 |
| WO2025196641A1 (ru) * | 2024-03-19 | 2025-09-25 | Биоплатформ Гмбх | Гибридные частицы, способ их получения и применение |
| WO2025230906A1 (en) * | 2024-04-29 | 2025-11-06 | Saliogen Therapeutics, Inc. | Lipid nanoparticle (lnp) formulations |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7638318B2 (en) * | 2003-09-26 | 2009-12-29 | Norvartis Ag | Seneca Valley virus based compositions and methods for treating disease |
| WO2006074526A1 (en) * | 2005-01-17 | 2006-07-20 | Viralytics Limited | Method and composition for treatment of neoplasms |
| PL2002003T3 (pl) * | 2005-05-27 | 2016-06-30 | Ospedale San Raffaele Srl | Wektor genetyczny zawierający mi-RNA |
| EP2125032A4 (en) * | 2007-02-20 | 2011-02-23 | Mayo Foundation | CANCER TREATMENT WITH VIRAL NUCLEIC ACID |
| TW201021853A (en) * | 2008-11-17 | 2010-06-16 | Enzon Pharmaceuticals Inc | Releasable cationic lipids for nucleic acids delivery systems |
| JP6093710B2 (ja) * | 2011-11-18 | 2017-03-08 | 日油株式会社 | 細胞内動態を改善したカチオン性脂質 |
| US9750819B2 (en) * | 2012-05-23 | 2017-09-05 | Ohio State Innovation Foundation | Lipid nanoparticle compositions and methods of making and methods of using the same |
| JP6396891B2 (ja) * | 2013-04-17 | 2018-09-26 | 新日本製薬株式会社 | 遺伝子改変コクサッキーウイルス |
| US20180000953A1 (en) * | 2015-01-21 | 2018-01-04 | Moderna Therapeutics, Inc. | Lipid nanoparticle compositions |
| RU2749050C2 (ru) * | 2016-01-27 | 2021-06-03 | Онкорус, Инк. | Онколитические вирусные векторы и их применение |
| RU2021127872A (ru) * | 2016-06-30 | 2021-11-09 | Онкорус, Инк. | Доставка терапевтических полипептидов посредством псевдотипированных онколитических вирусов |
| WO2018169063A1 (ja) * | 2017-03-17 | 2018-09-20 | 国立大学法人千葉大学 | 構造強化されたＳ－ＴｕＤを用いた新規がん治療法 |
| JP6832422B2 (ja) * | 2017-04-19 | 2021-02-24 | 国立大学法人 東京大学 | 遺伝子改変コクサッキーウイルス及び医薬組成物 |
| JP7187486B2 (ja) * | 2017-05-25 | 2022-12-12 | レイドス， インコーポレイテッド | Ｐｄ－１およびｃｔｌａ－４二重インヒビターペプチド |
| AU2018301701A1 (en) * | 2017-07-14 | 2020-02-27 | Elevatebio Technologies, Inc. | Encapsulated polynucleotides and methods of use |
-
2020
- 2020-01-03 EP EP20735846.6A patent/EP3906039A4/en active Pending
- 2020-01-03 TW TW109100228A patent/TW202043480A/zh unknown
- 2020-01-03 US US17/418,465 patent/US20220117902A1/en not_active Abandoned
- 2020-01-03 AU AU2020204989A patent/AU2020204989A1/en active Pending
- 2020-01-03 CA CA3124524A patent/CA3124524A1/en active Pending
- 2020-01-03 BR BR112021013155-8A patent/BR112021013155A2/pt unknown
- 2020-01-03 MX MX2021008146A patent/MX2021008146A/es unknown
- 2020-01-03 KR KR1020217024261A patent/KR20210113260A/ko not_active Ceased
- 2020-01-03 CN CN202080014652.4A patent/CN113453699A/zh active Pending
- 2020-01-03 JP JP2021538996A patent/JP2022516318A/ja active Pending
- 2020-01-03 WO PCT/US2020/012237 patent/WO2020142725A1/en not_active Ceased
- 2020-01-03 SG SG11202107282VA patent/SG11202107282VA/en unknown
-
2021
- 2021-06-28 IL IL284433A patent/IL284433A/en unknown
-
2024
- 2024-08-23 JP JP2024143254A patent/JP2024167285A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020142725A5 (https=) | ||
| Wang et al. | mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications | |
| Liu et al. | mRNA-based cancer therapeutics | |
| Feng et al. | RNA therapeutics-research and clinical advancements | |
| Pahle et al. | Vectors and strategies for nonviral cancer gene therapy | |
| JP2024167285A (ja) | カプセル化ポリヌクレオチド及び使用方法 | |
| Kauffman et al. | Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo | |
| JP2020530778A5 (https=) | ||
| Tyagi et al. | Exploiting nanotechnology for the development of microRNA-based cancer therapeutics | |
| JP2021522248A (ja) | 粒子状製剤用の凍結保護剤 | |
| Anand et al. | Metabolic stability and targeted delivery of oligonucleotides: advancing RNA therapeutics beyond the liver | |
| Son et al. | Development of mRNA vaccines/therapeutics and their delivery system | |
| Khan et al. | Lipid-based colloidal nanoparticles for applications in targeted vaccine delivery | |
| Abaza et al. | Lipid nanoparticles: a promising tool for nucleic acid delivery in cancer immunotherapy | |
| JPWO2022150485A5 (https=) | ||
| Zwolsman et al. | Engineering lipid nanoparticles for mRNA immunotherapy | |
| JP2025527583A (ja) | 脂質ナノ粒子の組成物 | |
| CN118556131A (zh) | 用于蛋白质表达的mRNA及其模板 | |
| Begum et al. | Advances in targeted gene delivery | |
| Wang et al. | Targeted gene delivery systems for T-cell engineering | |
| Arruda et al. | Innovative nonviral vectors for small-interfering RNA delivery and therapy | |
| JPWO2021243172A5 (https=) | ||
| JPWO2020102285A5 (https=) | ||
| RU2021123104A (ru) | Инкапсулированные полинуклеотиды рнк и способы их применения | |
| AU2023382622A1 (en) | Aerosolized lipid nanoparticles and uses thereof |